Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Inhibitory Effects of Standardized Leonurus japonicus Extract and Its Bioactive Leonurine on TNF-α-Induced Muscle Atrophy in L6 Myotubes

  • Lee, Jiyeon (Department of Biomaterials Science and Engineering, Yonsei University) ;
  • Kim, Changhee (Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University) ;
  • Lee, Hyerin (Graduate Program in Bioindustrial Engineering, Yonsei University) ;
  • Hwang, Jae-Kwan (Department of Biomaterials Science and Engineering, Yonsei University)
  • Received : 2020.05.14
  • Accepted : 2020.06.17
  • Published : 2020.12.28
Download PDF
⟨ Previous Next ⟩

Abstract

Muscle atrophy, characterized by a reduced number and size of myofibers, occurs due to immobilization, aging, and several chronic diseases. Leonurus japonicus, belonging to the Labiatae family, is widely used as a traditional medicine in Korea, China, and Japan. Previous studies have reported that L. japonicus has various physiological activities, such as anti-bacteria, anti-cancer, and liver protection. Leonurine, which is a major bioactive in L. japonicas, is known to possess biological effects including anti-inflammation, anti-fibrosis, anti-angiogenesis, and anti-diabetes. However, the preventive effects of L. japonicas and leonurine on muscle have not been reported. The current study aimed to determine the inhibitory effects of standardized L. japonicus extract (LJE) and leonurine on muscle atrophy by clarifying their underlying molecular mechanisms in tumor necrosis factor-alpha (TNF-α)-stimulated L6 myotubes. LJE and leonurine stimulated the phosphatidylinositol 3-kinase/Akt pathway that was reduced by TNF-α treatment. LJE and leonurine not only increased the mammalian target of rapamycin pathway for protein anabolism but also decreased the mRNA expression of E3 ubiquitin ligases by blocking the translocation of Forkhead box O, which is closely linked with proteolysis. Additionally, LJE and leonurine alleviated inflammatory responses by downregulating TNF-α and interleukin-6 mRNA expression and reducing the protein expression of nuclear factor-kappa B, a major transcriptional factor of proinflammatory cytokines. Collectively, LJE and leonurine have potential as therapeutic candidates for inhibiting the development of skeletal muscle atrophy by activating the PI3K/Akt pathway and reducing inflammatory responses.

Keywords

References

  1. Frontera WR, Ochala J. 2015. Skeletal muscle: a brief review of structure and function. Calcif. Tissue Int. 96: 183-195. https://doi.org/10.1007/s00223-014-9915-y
  2. Kunkel SD1 Suneja M, Ebert SM, Bongers KS, Fox DK, Malmberg SE, et al. 2011. mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass. Cell Metab. 13: 627-638. https://doi.org/10.1016/j.cmet.2011.03.020
  3. Le NH, Kim CS, Park T, Park JHY, Sung MK, Lee DG, et al. 2014. Quercetin protects against obesity-induced skeletal muscle inflammation and atrophy. Mediators Inflamm. 2014: 834294. https://doi.org/10.1155/2014/834294
  4. De Larichaudy J, Zufferli A, Serra F, Isidori AM, Naro F, Dessalle K, et al. 2012. TNF-α-and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism. Skelet. Muscle 2: 2. https://doi.org/10.1186/2044-5040-2-2
  5. Mukund K, Subramaniam S. 2020. Skeletal muscle: A review of molecular structure and function, in health and disease. Wiley Interdiscip. Rev. Syst. Biol. Med. 12: e1462.
  6. Sa BK, Kim C, Kim MB, Hwang JK. 2017. Panduratin A prevents tumor necrosis factor-alpha-induced muscle atrophy in L6 rat skeletal muscle cells. J. Med. Food 20: 1047-1054. https://doi.org/10.1089/jmf.2017.3970
  7. Bonaldo P, Sandri M. 2013. Cellular and molecular mechanisms of muscle atrophy. Dis. Model. Mech. 6: 25-39. https://doi.org/10.1242/dmm.010389
  8. Wang D-T, Yin Y, Yang Y-J, Lv P-J, Shi Y, Lu L, et al. 2014. Resveratrol prevents TNF-α-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes. Int. Immunopharmacol. 19: 206-213. https://doi.org/10.1016/j.intimp.2014.02.002
  9. Ascenzi F, Barberi L, Dobrowolny G, Villa Nova Bacurau A, Nicoletti C, Rizzuto E, et al. 2019. Effects of IGF-1 isoforms on muscle growth and sarcopenia. Aging Cell 18: e12954. https://doi.org/10.1111/acel.12954
  10. Egerman MA, Glass DJ. 2014. Signaling pathways controlling skeletal muscle mass. Crit. Rev. Biochem. Mol. Biol. 49: 59-68. https://doi.org/10.3109/10409238.2013.857291
  11. Miao L-L, Zhou Q-M, Peng C, Liu Z-H, Xiong L. 2019. Leonurus japonicus (Chinese motherwort), an excellent traditional medicine for obstetrical and gynecological diseases: A comprehensive overview. Biomed. Pharmacother. 117: 109060. https://doi.org/10.1016/j.biopha.2019.109060
  12. Shang X, Pan H, Wang X, He H, Li M. 2014. Leonurus japonicus Houtt.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J. Ethnopharmacol. 152: 14-32. https://doi.org/10.1016/j.jep.2013.12.052
  13. Li YY, Lin YK, Liu XH, Wang L, Yu M, Li DJ, et al. 2020. Leonurinenurine: from gynecologic medicine to pleiotropic agent. Chin. J. Integr. Med. 26: 152-160. https://doi.org/10.1007/s11655-019-3453-0
  14. Glass DJ. 2005. Skeletal muscle hypertrophy and atrophy signaling pathways. Int. J. Biochem. Cell Biol. 37: 1974-1984. https://doi.org/10.1016/j.biocel.2005.04.018
  15. Lenk K, Schuler G, Adams V. 2010. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J. Cachexia Sarcopenia Muscle 1: 9-21. https://doi.org/10.1007/s13539-010-0007-1
  16. LaVigne E, Jones A, Londono AS, Schauer A, Patterson D, Nadeau J, et al. 2015. Muscle growth in young horses: Effects of age, cytokines, and growth factors. J. Anim. Sci. 93: 5672-5680. https://doi.org/10.2527/jas.2015-9634
  17. Shavlakadze T, Chai J, Maley K, Cozens G, Grounds G, Winn N, et al. 2010. A growth stimulus is needed for IGF-1 to induce skeletal muscle hypertrophy in vivo. J. Cell Sci. 123: 960-971. https://doi.org/10.1242/jcs.061119
  18. Liu X, Pan L, Gong Q, Zhu Y. 2010. Leonurinenurine (SCM-198) improves cardiac recovery in rat during chronic infarction. Eur. J. Pharmacol. 649: 236-241. https://doi.org/10.1016/j.ejphar.2010.08.056
  19. Nader GA. 2005. Molecular determinants of skeletal muscle mass: getting the "AKT" together. Int. J. Biochem. Cell Biol. 37: 1985-1996. https://doi.org/10.1016/j.biocel.2005.02.026
  20. Wang C, Zhang Z, Xu T, Lou Y, Wang Q, Jin H, et al. 2018. Upregulating mTOR/ERK signaling with Leonurinenurine for promoting angiogenesis and tissue regeneration in a full-thickness cutaneous wound model. Food Funct. 9: 2374-2385. https://doi.org/10.1039/c7fo01289f
  21. Shen S, Yu H, Gan L, Ye Y, Lin L. 2019. Natural constituents from food sources: potential therapeutic agents against muscle wasting. Food Funct. 10: 6967-6986. https://doi.org/10.1039/C9FO00912D
  22. Qi J, Hong ZY, Xin H, Zhu YZ. 2010. Neuroprotective effects of Leonurinenurine on ischemia/reperfusion-induced mitochondrial dysfunctions in rat cerebral cortex. Biol. Pharm. Bull. 33: 1958-1964. https://doi.org/10.1248/bpb.33.1958
  23. Kim C, Kim MB, Hwang JK. 2020. Red bean extract inhibits immobilization-induced muscle atrophy in C57BL/6N mice. J. Med. Food 23: 29-36. https://doi.org/10.1089/jmf.2019.4426
  24. Park SG, Jegal KH, Jung JY, Byun SH, Park SM, Kim SC, et al. 2014. Leonurinenuri fructus ameliorates acute inflammation via the inhibition of NF-κB-mediated nitric oxide and pro-inflammatory cytokine production. Korean J. Ori. Med. Physiol. Pathol. 28: 178-185.
  25. Xu D, Chen M, Ren X, Ren X, Wu Y. 2014. Leonurinenurine ameliorates LPS-induced acute kidney injury via suppressing ROSmediated NF-κB signaling pathway. Fitoterapia 97: 148-155. https://doi.org/10.1016/j.fitote.2014.06.005
  26. Lee SJ, Yoo M, Go GY, Hwang J, Lee HG, Kim YK, et al. 2014. Tetrahydropalmatine promotes myoblast differentiation through activation of p38MAPK and MyoD. Biochem. Biophys. Res. Commun. 455: 147-152. https://doi.org/10.1016/j.bbrc.2014.10.115
  27. Dyle MC, Ebert SM, Cook DP, Kunkel SD, Fox DK, Bongers KS, et al. 2014. Systems-based discovery of tomatidine as a natural small molecule inhibitor of skeletal muscle atrophy. J. Biol. Chem. 289: 14913-14924. https://doi.org/10.1074/jbc.M114.556241
  28. Jang YJ, Son HJ, Choi YM, Ahn J, Jung CH, Ha TY. 2017. Apigenin enhances skeletal muscle hypertrophy and myoblast differentiation by regulating Prmt7. Oncotarget 8: 78300-78311. https://doi.org/10.18632/oncotarget.20962
  29. Choi WH, Son HJ, Jang YJ, Ahn J, Jung CH, Ha TY. 2017. Apigenin ameliorates the obesity-induced skeletal muscle atrophy by attenuating mitochondrial dysfunction in the muscle of obese mice. Mol. Nutr. Food Res. 61: doi: 10.1002/mnfr.201700218.
  30. Wen Y, Ushio H. 2017. Ferulic acid promotes hypertrophic growth of fast skeletal muscle in zebrafish model. Nutrients 9: 1066. https://doi.org/10.3390/nu9101066